210 related articles for article (PubMed ID: 23519426)
1. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
[TBL] [Abstract][Full Text] [Related]
2. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
Sachdeva H; Sehgal R; Kaur S
Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin along with herbal drug treatment reduces the percentage of regulatory T cells and decreased the severity of experimental visceral leishmaniasis.
Sachdeva H; Kaur S
J Microbiol Immunol Infect; 2018 Aug; 51(4):435-445. PubMed ID: 28655574
[TBL] [Abstract][Full Text] [Related]
4. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
[TBL] [Abstract][Full Text] [Related]
5. Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus.
Kaur S; Chauhan K; Sachdeva H
J Med Microbiol; 2014 Oct; 63(Pt 10):1328-1338. PubMed ID: 25082945
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis.
Sharma M; Sehgal R; Kaur S
PLoS Negl Trop Dis; 2012; 6(5):e1629. PubMed ID: 22563510
[TBL] [Abstract][Full Text] [Related]
7. Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo.
Sachdeva H; Sehgal R; Kaur S
Parasitol Int; 2014 Feb; 63(1):21-30. PubMed ID: 24103199
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic drug, carboplatin, protects mice against visceral leishmaniasis.
Kaur T; Makkar P; Randhawa K; Kaur S
Parasitol Res; 2013 Jan; 112(1):91-100. PubMed ID: 22961311
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Withania somnifera chemotypes NMITLI - 101R, 118R and Withaferin A against experimental visceral leishmaniasis.
Tripathi CD; Gupta R; Kushawaha PK; Mandal C; Misra Bhattacharya S; Dube A
Parasite Immunol; 2014 Jun; 36(6):253-65. PubMed ID: 24830833
[TBL] [Abstract][Full Text] [Related]
10. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
[TBL] [Abstract][Full Text] [Related]
12. Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
Afrin F; Chouhan G; Islamuddin M; Want MY; Ozbak HA; Hemeg HA
PLoS Negl Trop Dis; 2019 May; 13(5):e0007227. PubMed ID: 31071090
[TBL] [Abstract][Full Text] [Related]
13. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
Joshi J; Kaur S
Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
[TBL] [Abstract][Full Text] [Related]
14. Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.
Islamuddin M; Chouhan G; Farooque A; Dwarakanath BS; Sahal D; Afrin F
PLoS Negl Trop Dis; 2015 Jan; 9(1):e3321. PubMed ID: 25568967
[TBL] [Abstract][Full Text] [Related]
15. Antileishmanial effect of cisplatin against murine visceral leishmaniasis.
Kaur S; Sachdeva H; Dhuria S; Sharma M; Kaur T
Parasitol Int; 2010 Mar; 59(1):62-9. PubMed ID: 19853668
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
Joshi J; Malla N; Kaur S
Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
Gupta R; Kushawaha PK; Samant M; Jaiswal AK; Baharia RK; Dube A
J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191
[TBL] [Abstract][Full Text] [Related]
18. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
[TBL] [Abstract][Full Text] [Related]
19. To investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kDa + MPL-A against Leishmania donovani in BALB/c mice.
Joshi J; Kaur S
Parasite Immunol; 2014 Jan; 36(1):3-12. PubMed ID: 23964700
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
